Prognostic Value and Reproducibility of Pretreatment CT Texture Features in Stage III Non-Small Cell Lung Cancer

被引:154
|
作者
Fried, David V. [1 ,2 ]
Tucker, Susan L. [5 ]
Zhou, Shouhao [3 ]
Liao, Zhongxing [4 ]
Mawlawi, Osama [2 ]
Ibbott, Geoffrey [1 ,2 ]
Court, Laurence E. [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA
[2] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷 / 04期
关键词
TUMOR HETEROGENEITY; SURVIVAL; DISCUSSIONS; TOMOGRAPHY; PHYSICIANS; RADIATION;
D O I
10.1016/j.ijrobp.2014.07.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine whether pretreatment CT texture features can improve patient risk stratification beyond conventional prognostic factors (CPFs) in stage III non-small cell lung cancer (NSCLC). Methods and Materials: We retrospectively reviewed 91 cases with stage III NSCLC treated with definitive chemoradiation therapy. All patients underwent pretreatment diagnostic contrast enhanced computed tomography (CE-CT) followed by 4-dimensional CT (4D-CT) for treatment simulation. We used the average-CT and expiratory (T50-CT) images from the 4D-CT along with the CE-CT for texture extraction. Histogram, gradient, co-occurrence, gray tone difference, and filtration-based techniques were used for texture feature extraction. Penalized Cox regression implementing cross-validation was used for covariate selection and modeling. Models incorporating texture features from the 33 image types and CPFs were compared to those with models incorporating CPFs alone for overall survival (OS), local-regional control (LRC), and freedom from distant metastases (FFDM). Predictive Kaplan-Meier curves were generated using leave-one-out cross-validation. Patients were stratified based on whether their predicted outcome was above or below the median. Reproducibility of texture features was evaluated using test-retest scans from independent patients and quantified using concordance correlation coefficients (CCC). We compared models incorporating the reproducibility seen on test-retest scans to our original models and determined the classification reproducibility. Results: Models incorporating both texture features and CPFs demonstrated a significant improvement in risk stratification compared to models using CPFs alone for OS (P = .046), LRC (P = .01), and FFDM (P = .005). The average CCCs were 0.89, 0.91, and 0.67 for texture features extracted from the average-CT, T50-CT, and CE-CT, respectively. Incorporating reproducibility within our models yielded 80.4% (+/- 3.7% SD), 78.3% (+/- 4.0% SD), and 78.8% (+/- 3.9% SD) classification reproducibility in terms of OS, LRC, and FFDM, respectively. Conclusions: Pretreatment tumor texture may provide prognostic information beyond that obtained from CPFs. Models incorporating feature reproducibility achieved classification rates of similar to 80%. External validation would be required to establish texture as a prognostic factor. (C) 2014 Elsevier Inc.
引用
收藏
页码:834 / 842
页数:9
相关论文
共 50 条
  • [11] Stage III Non-small Cell Lung Cancer Management in England
    Adizie, J. B.
    Khakwani, A.
    Beckett, P.
    Navani, N.
    West, D.
    Woolhouse, I
    Harden, S., V
    CLINICAL ONCOLOGY, 2019, 31 (10) : 688 - 696
  • [12] Prognostic value of metabolic tumor volume of pretreatment 18F-FAMT PET/CT in non-small cell lung Cancer
    Kumasaka, Soma
    Nakajima, Takahito
    Arisaka, Yukiko
    Tokue, Azusa
    Achmad, Arifudin
    Fukushima, Yasuhiro
    Shimizu, Kimihiro
    Kaira, Kyoichi
    Higuchi, Tetsuya
    Tsushima, Yoshito
    BMC MEDICAL IMAGING, 2018, 18
  • [13] Non-Small Cell Lung Cancer: Histopathologic Correlates for Texture Parameters at CT
    Ganeshan, Balaji
    Goh, Vicky
    Mandeville, Henry C.
    Quan Sing Ng
    Hoskin, Peter J.
    Miles, Kenneth A.
    RADIOLOGY, 2013, 266 (01) : 326 - 336
  • [14] Prognostic value of positron emission tomography in resected stage IA non-small cell lung cancer
    Chou, Hsiu-Ping
    Lin, Kuan-Hsun
    Huang, Hsu-Kai
    Lin, Li-Fan
    Chen, Ying-Yi
    Wu, Ti-Hui
    Lee, Shih-Chun
    Chang, Hung
    Huang, Tsai-Wang
    EUROPEAN RADIOLOGY, 2021, 31 (10) : 8021 - 8029
  • [15] Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non-Small Cell Lung Cancer
    Tuminello, Stephanie
    Petralia, Francesca
    Veluswamy, Rajwanth
    Wang, Pei
    Flores, Raja
    Taioli, Emanuela
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (07): : 350 - 355
  • [16] Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: A systematic review and meta-analysis
    Hu, Yuanyuan
    Shen, Jie
    Liu, RuiKe
    Feng, ZhiMei
    Zhang, ChangNing
    Ling, Li
    Chen, LiBo
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2018, 33 (04) : 372 - 378
  • [17] Prognostic Value of Chromatin Structure Typing in Early-Stage Non-Small Cell Lung Cancer
    Mao, Luning
    Wu, Jianghua
    Zhang, Zhongjie
    Mao, Lijun
    Dong, Yuejin
    He, Zufeng
    Wang, Haiyue
    Chi, Kaiwen
    Jiang, Yumeng
    Lin, Dongmei
    CANCERS, 2023, 15 (12)
  • [18] Prognostic Value of Volumetric Parameters on Staging and Posttreatment FDG PET/CT in Patients With Stage IV Non-Small Cell Lung Cancer
    Lee, Jeong Won
    Lee, Sun Min
    Yun, Mijin
    Cho, Arthur
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (05) : 347 - 353
  • [19] Prognostic Factors in Advanced-Stage Non-small Cell Lung Cancer
    Balta, Berrin Zinnet
    Ure, Oznur Sari
    Erturan, Serdar
    Aydin, Gunay
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2013, 51 (02): : 56 - 60
  • [20] Prognostic value of metformin for non-small cell lung cancer patients with diabetes
    Xu, Tongbai
    Li, Dongsheng
    He, Yuan
    Zhang, Fuliang
    Qiao, Man
    Chen, Yanhua
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16